Gabor Pogany
Overview
Explore the profile of Gabor Pogany including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Csanadi M, Kalo Z, Rutten-van Molken M, Looman W, Huic M, Ercevic D, et al.
Health Policy
. 2022 Sep;
126(11):1173-1179.
PMID: 36057453
The importance of integrated care will increase in future health systems due to aging populations and patients with chronic multimorbidity, however, such complex healthcare interventions are often developed and implemented...
2.
Pogany G, Csanadi M, Pitter J, Zemplenyi A, Body E, Bojtor Z, et al.
Orv Hetil
. 2021 Nov;
162(45):1818-1825.
PMID: 34747362
Summary: Introduction: In Hungary, significant achievements have been made in the care of patients with rare diseases in recent years. A next step could be the establishment of the National...
3.
Pogany G
Orv Hetil
. 2017 Nov;
158(47):1851-1856.
PMID: 29153019
The aim was to present the actual situation of rare diseases, especially to characterize the circumstances in Hungary. The most important developments were summarized which could help the care of...
4.
Pentek M, Herczegfalvi A, Molnar M, Szonyi L, Kosztolanyi G, Pfliegler G, et al.
Ideggyogy Sz
. 2016 Jul;
69(5-6):183-93.
PMID: 27468608
Background And Purpose: Data on the disease burden of Duchenne Muscular Dystrophy are scarce in Hungary. The aim of this study was to assess patients' and their caregivers' health related...
5.
Pentek M, Gulacsi L, Brodszky V, Baji P, Boncz I, Pogany G, et al.
Eur J Health Econ
. 2016 Apr;
17 Suppl 1:89-98.
PMID: 27062257
Objectives: To assess the health-related quality of life (HRQOL) of patients with mucopolysaccharidosis (MPS) and their caregivers and to quantify the disease-related costs from a societal perspective. Methods: In the...
6.
Pentek M, Kosztolanyi G, Melegh B, Halasz A, Pogany G, Baji P, et al.
Orv Hetil
. 2014 Oct;
155(42):1673-84.
PMID: 25305725
Introduction: Data on disease burden of cystic fibrosis in Hungary are scarce. Aim: To assess quality of life and resource utilisations of patients with cystic fibrosis. Method: In a cross-sectional...
7.
Pogany G
Orv Hetil
. 2014 Feb;
155(9):329-33.
PMID: 24566696
The aim of the author is to discuss special issues of rare diseases, with emphasis on circumstances present in Hungary, including those leading to the foundation of the non-governmental organization,...
8.
Pogany G
Magy Onkol
. 2013 Apr;
57(1):11-5.
PMID: 23573516
Our goal was to overview the situation of personalized medicine, especially to characterize the role of patient organizations. We embedded this process into the on-going procedures of the transformation of...
9.
Foldvari A, Szy I, Sandor J, Pogany G, Kosztolanyi G
Orv Hetil
. 2012 Jul;
153(30):1185-90.
PMID: 22835635
Unlabelled: The long diagnostic delay is a characteristic problem of rare disease patients. Aims: Diagnostic delay was studied in 14 countries by EurordisCare2 involving patient organizations. Methods: 252 Hungarian patients...
10.
Harisi R, Kenessey I, Olah J, Timar F, Babo I, Pogany G, et al.
Anticancer Res
. 2009 Aug;
29(8):2981-5.
PMID: 19661304
For the control of tumor metastasis it is important to identify chemical compounds with antimigratory potency. Agents acting against single cell and cluster type migration are necessary for successful antimetastatic...